PT2590949E - Método para o fabrico de quinolina-3-carboxamidas - Google Patents
Método para o fabrico de quinolina-3-carboxamidas Download PDFInfo
- Publication number
- PT2590949E PT2590949E PT117324210T PT11732421T PT2590949E PT 2590949 E PT2590949 E PT 2590949E PT 117324210 T PT117324210 T PT 117324210T PT 11732421 T PT11732421 T PT 11732421T PT 2590949 E PT2590949 E PT 2590949E
- Authority
- PT
- Portugal
- Prior art keywords
- carboxamides
- quinoline
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36284910P | 2010-07-09 | 2010-07-09 | |
| EP10169162 | 2010-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2590949E true PT2590949E (pt) | 2016-03-07 |
Family
ID=43348982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117324210T PT2590949E (pt) | 2010-07-09 | 2011-07-07 | Método para o fabrico de quinolina-3-carboxamidas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8871936B2 (pt) |
| EP (1) | EP2590949B1 (pt) |
| JP (1) | JP5881691B2 (pt) |
| KR (1) | KR101855195B1 (pt) |
| CN (1) | CN103119023B (pt) |
| AU (1) | AU2011275720B2 (pt) |
| BR (1) | BR112012033465A2 (pt) |
| CA (1) | CA2802006C (pt) |
| DK (1) | DK2590949T5 (pt) |
| EA (1) | EA021171B1 (pt) |
| ES (1) | ES2563208T3 (pt) |
| HK (1) | HK1183864A1 (pt) |
| IL (1) | IL223583A (pt) |
| MX (1) | MX2013000288A (pt) |
| NZ (1) | NZ604176A (pt) |
| PL (1) | PL2590949T3 (pt) |
| PT (1) | PT2590949E (pt) |
| SG (1) | SG186430A1 (pt) |
| UA (1) | UA108381C2 (pt) |
| WO (1) | WO2012004338A1 (pt) |
| ZA (1) | ZA201209370B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103626701A (zh) * | 2012-08-28 | 2014-03-12 | 天津药物研究院 | 一种制备喹啉衍生物的方法 |
| CN103626702A (zh) * | 2012-08-30 | 2014-03-12 | 天津药物研究院 | 一种制备喹啉酮衍生物的方法 |
| CN105367492B (zh) * | 2014-08-28 | 2018-07-03 | 杭州普晒医药科技有限公司 | 他喹莫德的晶型及其制备方法、其药物组合物和用途 |
| AU2015316824B2 (en) | 2014-09-23 | 2020-10-29 | Active Biotech Ab | Quinoline carboxamides for use in the treatment of multiple myeloma |
| MX2017006110A (es) | 2014-11-19 | 2017-07-27 | Active Biotech Ab | Carboxamidas de quinolina para usarse en el tratamiento de leucemia. |
| KR101807124B1 (ko) * | 2015-12-02 | 2017-12-07 | 현대자동차 주식회사 | 연료전지차량의 비상 운전 제어 방법 |
| EP4114368A1 (en) | 2020-03-03 | 2023-01-11 | Active Biotech AB | Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy |
| CN111732540B (zh) * | 2020-07-20 | 2020-11-13 | 湖南速博生物技术有限公司 | 一种罗喹美克的制备方法 |
| EP4185292A1 (en) | 2020-07-23 | 2023-05-31 | Erasmus University Rotterdam Medical Center | S100 proteins as novel therapeutic targets in myeloproliferative neoplasms |
| JP2024503372A (ja) | 2021-01-18 | 2024-01-25 | アクティブ バイオテック エイビー | 骨髄異形成症候群の処置における使用のためのタスキニモドまたはその薬学的に許容される塩 |
| EP4346773A1 (en) | 2021-05-25 | 2024-04-10 | Active Biotech AB | A plurality of tasquinimod particles and use thereof |
| EP4363404A1 (en) | 2021-07-02 | 2024-05-08 | Active Biotech AB | A pharmaceutical product containing tasquinimod and a method for assessing the purity of said product |
| KR20230149402A (ko) | 2022-04-20 | 2023-10-27 | 목포대학교산학협력단 | 판막 석회화 예방 또는 치료용 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3769292A (en) * | 1972-04-28 | 1973-10-30 | Warner Lambert Co | N-(pyridyl)2h 1-benzothiopyran-3-carboxamide-4-hydroxy 1,1-dioxides |
| US3868379A (en) | 1972-04-28 | 1975-02-25 | Warner Lambert Co | Heterocyclic amides of 4-hydroxy-2H-1-benzothiopyran-3-carboxylic acid 1,1-dioxide |
| AT345847B (de) * | 1974-11-08 | 1978-10-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxid und deren salze |
| US4786644A (en) * | 1987-11-27 | 1988-11-22 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinolinecarboxamide |
| US5912349A (en) | 1997-01-31 | 1999-06-15 | Pharmacia & Upjohn Company | Process for the preparation of roquinimex |
| US6077851A (en) | 1998-04-27 | 2000-06-20 | Active Biotech Ab | Quinoline derivatives |
| SE9801474D0 (sv) | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
| US6133285A (en) | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
| US7560557B2 (en) * | 2002-06-12 | 2009-07-14 | Active Biotech Ag | Process for the manufacture of quinoline derivatives |
| US6875869B2 (en) | 2002-06-12 | 2005-04-05 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
| SE0201778D0 (sv) * | 2002-06-12 | 2002-06-12 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
| EP2252299B1 (en) * | 2008-02-15 | 2014-03-19 | Merck Sharp & Dohme Corp. | Fused pyridone m1 receptor positive allosteric modulators |
| US8552194B2 (en) * | 2008-04-28 | 2013-10-08 | Actavis Group Ptc Ehf | Process for preparing quinoline-3-carboxamide derivatives |
-
2011
- 2011-07-07 EA EA201300103A patent/EA021171B1/ru not_active IP Right Cessation
- 2011-07-07 SG SG2012094371A patent/SG186430A1/en unknown
- 2011-07-07 US US13/809,233 patent/US8871936B2/en active Active
- 2011-07-07 JP JP2013517387A patent/JP5881691B2/ja active Active
- 2011-07-07 MX MX2013000288A patent/MX2013000288A/es active IP Right Grant
- 2011-07-07 NZ NZ604176A patent/NZ604176A/en not_active IP Right Cessation
- 2011-07-07 PL PL11732421T patent/PL2590949T3/pl unknown
- 2011-07-07 CN CN201180033827.7A patent/CN103119023B/zh active Active
- 2011-07-07 BR BR112012033465A patent/BR112012033465A2/pt not_active Application Discontinuation
- 2011-07-07 KR KR1020137001660A patent/KR101855195B1/ko active IP Right Grant
- 2011-07-07 CA CA2802006A patent/CA2802006C/en active Active
- 2011-07-07 ES ES11732421.0T patent/ES2563208T3/es active Active
- 2011-07-07 AU AU2011275720A patent/AU2011275720B2/en active Active
- 2011-07-07 UA UAA201300947A patent/UA108381C2/uk unknown
- 2011-07-07 EP EP11732421.0A patent/EP2590949B1/en active Active
- 2011-07-07 PT PT117324210T patent/PT2590949E/pt unknown
- 2011-07-07 WO PCT/EP2011/061490 patent/WO2012004338A1/en active Application Filing
- 2011-07-07 DK DK11732421.0T patent/DK2590949T5/en active
-
2012
- 2012-12-11 ZA ZA2012/09370A patent/ZA201209370B/en unknown
- 2012-12-12 IL IL223583A patent/IL223583A/en active IP Right Grant
-
2013
- 2013-10-03 HK HK13111271.2A patent/HK1183864A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130091730A (ko) | 2013-08-19 |
| CN103119023B (zh) | 2014-12-24 |
| CA2802006A1 (en) | 2012-01-12 |
| NZ604176A (en) | 2014-10-31 |
| EA201300103A1 (ru) | 2013-06-28 |
| JP2013529672A (ja) | 2013-07-22 |
| MX2013000288A (es) | 2013-05-22 |
| IL223583A (en) | 2016-03-31 |
| JP5881691B2 (ja) | 2016-03-09 |
| WO2012004338A1 (en) | 2012-01-12 |
| US20130109860A1 (en) | 2013-05-02 |
| KR101855195B1 (ko) | 2018-05-08 |
| EA021171B1 (ru) | 2015-04-30 |
| CN103119023A (zh) | 2013-05-22 |
| BR112012033465A2 (pt) | 2017-06-20 |
| CA2802006C (en) | 2018-09-25 |
| ZA201209370B (en) | 2014-03-26 |
| AU2011275720A1 (en) | 2013-01-10 |
| DK2590949T3 (en) | 2016-02-29 |
| DK2590949T5 (en) | 2016-05-23 |
| EP2590949A1 (en) | 2013-05-15 |
| US8871936B2 (en) | 2014-10-28 |
| ES2563208T3 (es) | 2016-03-11 |
| AU2011275720B2 (en) | 2015-05-14 |
| SG186430A1 (en) | 2013-01-30 |
| UA108381C2 (uk) | 2015-04-27 |
| PL2590949T3 (pl) | 2016-06-30 |
| EP2590949B1 (en) | 2015-11-25 |
| HK1183864A1 (zh) | 2014-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2552873A4 (en) | PREPARATION FOR HEXAFLUOR-2-BUTEN | |
| IL248217B (en) | A method for the production of inganol-3-englate | |
| HK1183864A1 (zh) | 生產喹啉- -羧酰胺的方法 | |
| EP2793780A4 (en) | METHOD FOR PRODUCING A TAMPON | |
| PL2632581T3 (pl) | Sposób wytwarzania wypełnionych granulek | |
| EP2537825A4 (en) | PROCESS FOR PREPARING 1-AMINO-1-ALKOXYCARBONYL-2-VINYLCYCLOPROPANE | |
| EP2560249A4 (en) | METHOD FOR MANUFACTURING CONNECTOR | |
| EP2542523A4 (en) | PROCESS FOR PRODUCING EPSILON-CAPROLACTAM | |
| EP2657223A4 (en) | METAL-SALEN COMPLEX COMPOUND AND PROCESS FOR PRODUCING THE SAME | |
| GB2485831B (en) | A method of manufacturing a component | |
| EP2653481A4 (en) | PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE | |
| GB201008900D0 (en) | Method of machining | |
| AP3415A (en) | Method for manufacturing of naltrexone | |
| EP2754508A4 (en) | METHOD FOR PRODUCING A SEAMLESS METAL TUBE | |
| GB201007454D0 (en) | Method of determining tolerance | |
| PL2476684T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| GB201006348D0 (en) | Method of manufacturing a component | |
| EP2752253A4 (en) | METHOD FOR PRODUCING A SEAMLESS METAL TUBE | |
| PL2476685T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| EP2586774A4 (en) | PROCESS FOR THE PREPARATION OF RANOLAZINE | |
| GB201119607D0 (en) | Method of manufacture | |
| PL2476686T3 (pl) | Sposób wytwarzania alkilofosforanów | |
| PL393115A1 (pl) | Sposób wytwarzania jogurtu | |
| PL389965A1 (pl) | Sposób wytwarzania 3ß - hydroksy-17 a-oxa-D-homo-5α-androst-17-onu | |
| EP2496096A4 (en) | PROCESS FOR PRODUCING MAGNOLIIDAE COMPOUNDS |